Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Genome binding/occupancy profiling by high throughput sequencing | BW | Kornelia Polyak | |||||
GSE104988 |
KDM5B links cellular transcriptome heterogeneity to therapy resistance
|
|
333 |
|
Kornelia Polyak | Oct 03, 2018 | ||
GSE131102 |
Synthetic lethal and resistance interactions with BET bromodomain inhibitors
|
|
210 |
|
Kornelia Polyak | Mar 30, 2020 | ||
GSE38548 |
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer
|
|
106 | Kornelia Polyak | Jun 09, 2015 | |||
GSE202776 |
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer
|
|
386 |
|
Kornelia Polyak | Nov 09, 2023 | ||
GSE69112 |
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [ChIP-Seq 3]
|
|
23 | Kornelia Polyak | Jun 10, 2015 | |||
GSE104983 |
KDM5B links cellular transcriptome heterogeneity to therapy resistance (ChIP-Seq)
|
|
171 | Kornelia Polyak | Oct 03, 2018 | |||
GSE131026 |
Synthetic lethal and resistance interactions with BET bromodomain inhibitors [ATAC-Seq]
|
|
16 | Kornelia Polyak | Mar 30, 2020 | |||
GSE131097 |
Synthetic lethal and resistance interactions with BET bromodomain inhibitors [ChIP-Seq]
|
|
61 | Kornelia Polyak | Mar 30, 2020 | |||
GSE163360 |
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states [ChIP-seq]
|
|
14 | Kornelia Polyak | Nov 02, 2022 | |||
GSE163397 |
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states
|
|
131 | Kornelia Polyak | Nov 02, 2022 | |||
GSE202766 |
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (H3K27ac cell lines ChIP-Seq)
|
|
60 |
|
Kornelia Polyak | Nov 09, 2023 | ||
GSE202767 |
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PRRX1 ChIP-Seq)
|
|
31 |
|
Kornelia Polyak | Nov 09, 2023 | ||
GSE202772 |
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)
|
|
24 |
|
Kornelia Polyak | Nov 09, 2023 | ||
GSE229426 |
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer [ATAC-seq]
|
|
12 | Kornelia Polyak | Aug 15, 2023 | |||
GSE229428 |
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer
|
|
34 | Kornelia Polyak | Aug 15, 2023 | |||
GSE237390 |
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 [ChIP-seq]
|
|
54 | Kornelia Polyak | Apr 24, 2024 | |||
GSE237392 |
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3
|
|
81 | Kornelia Polyak | Apr 24, 2024 | |||
GSE249459 |
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies [ATAC-seq]
|
|
24 | Kornelia Polyak | Apr 24, 2024 | |||
GSE249574 |
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies
|
|
64 | Kornelia Polyak | Apr 24, 2024 |